Intra‐Articular Purified Exosome Product and Hyaluronan Attenuate Osteoarthritis Progression in a Minimally Invasive Turkey Model
Journal of Orthopaedic Research · 2026-05 · 44 (5)
DOI: 10.1002/jor.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 29.04.2026. Verfasst von Xing Lei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Hyaluronic Acid, Exosomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Arthritis Treatment Award.
Abstract (Originalsprache)
Our study aimed to develop a novel, reproducible, minimally invasive turkey knee osteoarthritis (OA) model and evaluate whether intra‐articular hyaluronan (HA) alone or combined with purified exosome product (PEP) attenuates OA‐related functional and structural deterioration. OA was induced arthroscopically by transection of the anterior and posterior cruciate ligaments with resection of the anterior horn of the medial meniscus. Animals received intra‐articular injections of saline, HA, or PEP + HA at postoperative 2–5 weeks. Gait was assessed at 4, 8, and 12 weeks, and cartilage degeneration, subchondral bone sclerosis, osteophyte formation, synovial fibrosis, heterotopic ossification, and meniscal integrity were evaluated by quantitative CT and histology at week 12. Compared with saline, HA improved lameness, preserved cartilage glycosaminoglycan content, and reduced meniscal rupture, subchondral bone sclerosis, and periarticular heterotopic ossification. PEP + HA provided additional benefits, including prolonged stance phase, reduced synovial fibrosis, and greater chondroprotection than HA alone, while plantar pressure variables, subchondral bone remodeling, and patellar osteophytes did not differ between HA and PEP + HA. This turkey model reliably produces human‐like OA changes and enables longitudinal functional and structural assessment. Intra‐articular HA mitigated OA progression, and the addition of PEP conferred incremental joint protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Orthopedic Surgery, Linyi People's Hospital, Linyi, China.
- Department of Orthopedic Surgery, Chongqing Medical University, Chongqing, China.
Förderung
- Arthritis Treatment Award
Zitieren
APA
Lei, X., Wang, L., Reisdorf, R. L., Brosig, M. A., Moran, S. L., Evans, C. H., & Zhao, C. (2026). Intra‐Articular Purified Exosome Product and Hyaluronan Attenuate Osteoarthritis Progression in a Minimally Invasive Turkey Model. Journal of Orthopaedic Research, 44(5). https://doi.org/10.1002/jor.70207
Vancouver
Lei X, Wang L, Reisdorf RL, Brosig MA, Moran SL, Evans CH, et al. Intra‐Articular Purified Exosome Product and Hyaluronan Attenuate Osteoarthritis Progression in a Minimally Invasive Turkey Model. Journal of Orthopaedic Research. 2026;44(5). doi:10.1002/jor.70207
BibTeX
@article{Lei2026,
author = {Lei, Xing and Wang, Lei and Reisdorf, Ramona L and Brosig, Maggie A and Moran, Steven L and Evans, Christopher H and Zhao, Chunfeng},
title = {Intra‐Articular Purified Exosome Product and Hyaluronan Attenuate Osteoarthritis Progression in a Minimally Invasive Turkey Model},
journal = {Journal of Orthopaedic Research},
year = {2026},
volume = {44},
number = {5},
doi = {10.1002/jor.70207}
}
EUVIMED